DJ Khaled told People, in an interview published November 12 and reported by Us Weekly, that GLP-1 medication helped him lose 90 pounds over the past year. The producer, 50, named the drug: Wegovy.

GLP-1 medications are the class now dominating obesity treatment, and Wegovy is one of the brand names in it. Khaled is not describing a supplement or a peptide bought online, he is describing a prescription product he said he started taking roughly a year ago.

The moment he points to

The trigger, by his account, was an October 2025 show. "There's a part of my show where I get on my knees and give thanks and show my gratitude," he said. "So, I get on my knees, but I remember I couldn't really get up."

Friends followed up afterward. One told him he had been breathing hard, and ten minutes later, he said, someone else said the same thing.

The numbers he gave

Khaled said he weighed around 295 to 300 pounds at the time and now sits around 200 to 212 pounds. He also described adding exercise: golf, and walking 10,000 steps a day.

Those are self-reported figures from an interview, not clinic measurements, and that distinction matters more than it usually gets credit for in celebrity weight coverage. He framed the medication as support rather than substitution: "The motivation was there, the inspiration was there, working out and trying to eat better, but I needed help."

What is on the record, and what is not

What Khaled said on the record is that he used Wegovy, that he changed how he moves, and that he feels better. "I'm just way healthier. I've got more energy," he said, adding that his doctor had told him he should "be studied, that's how healthy you are."

What is not in the interview is any dose, any duration beyond "a year ago," any lab result, or any independent clinician assessing the case. No trial data appears anywhere in the coverage, because this is an interview, not a study.

Why this one is worth noting

The useful part is the specificity. A named drug, a named starting weight, a named current weight and a named reason for starting is more than most celebrity GLP-1 stories offer, and it is still a single person's account of a single year.